Dr. Galitzer has more than ten years of experience in medical research and molecular biology and was mentored by two world renowned researchers in the field of PTH and calcium regulation. He has served as COO since February 2014, and on partial time as Director of Scientific Development since July 2012. Between August 2010 and February 2014 Dr. Galitzer was an analyst and COO for Hadasit Bio Holdings Ltd., a publicly traded company on the TASE and OTC markets. Dr. Galitzer is the co-founder and Chief Operating Officer of Optivasive Inc. He has written numerous publications in tier one peer reviewed articles and has lectured and presented in international conferences and universities. Dr. Galitzer received his Ph.D. from the Hebrew University Medical School in Jerusalem, and his M.B.A. from Bar-Ilan University in Israel.